BSEBoard Meeting5 Aug 2026 · 5 Aug 2026, 05:17 pm

Outcome of the Board Meeting - Unaudited Financial Results (standalone and consolidated) for the first quarter ended 30 June 2026

Aster DM Quality Care Ltd · 540975

✦ AI SummaryResults

Aster DM Quality Care Ltd has announced its unaudited financial results for the first quarter ended 30 June 2026, with the Board of Directors approving the results as reviewed and recommended by the Audit Committee. The results will be published in newspapers as required under the Listing Regulations.

Analysis Scores

Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk2/10
Liquidity Impact5/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Aster DM Quality Care Ltd - 540975 - Board Meeting Outcome for Outcome Of The Board Meeting - Unaudited Financial Results (Standalone And Consolidated) For The First Quarter Ended 30 June 2026

Attachments (1)

📄

a122fae4-5403-490e-a2be-8fe71c18bfae.pdf

pdf

Download →
View document text
5 August 2026 BSE Limited The National Stock Exchange of India Limited Phiroze Jeejeebhoy Towers, Exchange Plaza, Bandra Kurla Complex, Dalal Street, Mumbai 400001, Bandra (East), Mumbai 400051, Maharashtra, India Maharashtra, India Scrip Code: 540975 Scrip Symbol: ASTERDM Dear Sir/Madam, Subject: Outcome of the Board Meeting - Unaudited Financial Results (standalone and consolidated) for the first quarter ended 30 June 2026 Ref: Regulation 30 and 33 of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015 (“Listing Regulations”) With reference to our letter dated 30 July 2026 and in accordance with Regulation 30 and 33 of the Listing Regulations, we wish to inform you that the Board of Directors of Aster DM Quality Care Limited (formerly known as Aster DM Healthcare Limited) (“the Board” and “the Company”, respectively) at its meeting held today i.e. 5 August 2026, inter alia, has approved the unaudited financial results (standalone and consolidated) of the Company for the quarter ended 30 June 2026 (“UFRs”), as reviewed and recommended by the Audit Committee. A copy of UFRs, along with the limited review report thereon issued by M/s. Deloitte Haskins & Sells, Statutory Auditors are enclosed. The UFRs shall be published in the newspapers as required under the Listing Regulations. The Meeting of the Board of Directors commenced at 11:30 AM (IST) and concluded at 04:40 PM (IST). The above information will also be hosted on the website of the Company i.e. www.asterqualitycare.com This is for your information and records. Thanking you, For Aster DM Quality Care Limited (Formerly known as Aster DM Healthcare Limited) Hemish Purushottam Company Secretary and Compliance Officer M. No. A24331 Aster DM Quality Care Limited (Formerly Aster DM Healthcare Limited) Registered Office: No 7-1-450/20, Plot No-04, Mythri Vihar, Sanjeev CIN: L85110TS2008PLC207383 Reddy Nagar, Ameerpet, Hyderabad, Telangana, India, 500038 Telephone: +91 96060 61833 E-mail: cs@asterqualitycare.com Corporate Office: Brigade Deccan Heights 20th & 12th Floor, Website: www.asterqualitycare.com #42, 5th Mile, Tumkur Rd, Yeshwanthpur Industrial Area, Phase 1, Yeshwanthpur, Bengaluru-560022 Chartered Accountants Prestige Trade Tower, Level 19 46, Palace Road, High Grounds Bengaluru 560 001 Karnataka, India Tel: +91 8061886000 Fax: +91 806188 6011 UNAUDITED STANDALONE FINANCIAL RESULTS TO THE BOARD OF DIRECTORS OF ASTER DM QUALITY CARE LIMITED (formerly known as ASTER DM HEALTHCARE LIMITED) 1. We have reviewed the accompanying Statement of Unaudited Standalone Financial Results of ASTER DM QUALITY CARE LIMITED (formerly known as ASTER DM HEALTHCARE LIMITED) interim financial ) for the quarter ended 30 June 2026 pursuant to the requirement of Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended . the recognition and measurement principles laid down in the Indian Accounting of the Companies Act, 2013 read with relevant rules issued thereunder and other accounting principles generally accepted in India. Our responsibility is to express a conclusion on the Statement based on our review. 3. We conducted our review of the Statement in accordance with the Standard on Review India (ICAI). A review of interim financial information consists of making inquiries, and applying analytical and other review procedures. A review is substantially less in scope than an audit conducted in accordance with Standards on Auditing specified under section 143(10) of the Companies Act, 2013 and consequently does not enable us to obtain assurance that we would become aware of all significant matters that might be identified in an audit. Accordingly, we do not express an audit opinion. We also performed procedures in accordance with the circular issued by the SEBI under Regulation 33(8) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended, to the extent applicable. 4. Based on our review conducted as stated in paragraph 3 above, nothing has come to our attention that causes us to believe that the accompanying Statement, prepared in accordance with the recognition and measurement principles laid down in the aforesaid Indian Accounting Standard and other accounting principles generally accepted in India, has not disclosed the information required to be disclosed in terms of the Listings Regulations, including the manner in which it is to be disclosed, or that it contains any material misstatement. 5. The Unaudited Standalone Financial Results includes the interim financial information of the ESOP trust which have not been reviewed by its auditor whose interim financial information reflect total revenue of INR 0.56 crores, total net profit after tax of INR 0.42 crores and total comprehensive income of INR 0.42 crores for the quarter ended 30 June 2026, as considered in the Statement. According to the information and explanations given to us by the Management, these interim financial information are not material to the Company. Our conclusion on the Statement is not modified in respect of our reliance on the interim financial information certified by the Management. For Deloitte Haskins & Sells Chartered Accountants 008072S) Ankit Daga (Partner) (Membership No. 512486) (UDIN: 26512486AFXMIV2992) Place: Bengaluru Date: 5 August 2026 Page 2 of 2 Aster DM Quality Care Limited (Formerly known as Aster DM Healthcare Limited) CIN : L85110TS2008PLC207383 Registered office : No 7-1-450/20, Plot No-04, Mythri Vihar, Sanjeev Reddy Nagar, Ameerpet, Hyderabad, Telangana, India, 500038 Statement of Unaudited Standalone Financial Results for the quarter ended 30 June 2026 (Amount in INR crores) Quarter ended Year ended Particulars 30 June 2026 31 March 2026 30 June 2025 31 March 2026 (refer Note 9) (Unaudited) (Audited) 1 Income Revenue from operations 725.73 655.10 613.04 2,615.70 Other income 39.03 40.55 38.43 155.03 Total income 764.76 695.65 651.47 2,770.73 2 Expenses Purchase of medicines and medical consumables 162.04 122.14 130.46 530.68 Changes in inventories (12.28) 8.15 ( 0.56) 8.49 Professional fees to consultant doctors 165.48 149.99 136.22 579.85 Laboratory outsourcing charges 21.91 18.98 17.92 78.55 Employee benefits expense 121.39 103.94 91.48 403.45 Finance costs 24.02 20.98 21.64 87.27 Depreciation and amortisation expenses 41.32 37.57 37.88 154.02 Other expenses 120.20 113.53 104.01 464.30 Total expenses 644.08 575.28 539.05 2,306.61 3 Profit before exceptional items and tax (1-2) 120.68 120.37 112.42 464.12 4 Exceptional items (refer Note 7) ( 109.79) (77.73) ( 4.39) (89.92) 5 Profit before tax (3+4) 10.89 42.64 108.03 374.20 6 Tax expenses Current tax 35.12 19.93 28.87 124.37 Deferred tax (9.93) (4.75) ( 1.43) (17.99) Total tax expense 25.19 15.18 27.44 106.38 7 Profit/(Loss) for the period / year (5-6) (14.30) 27.46 80.59 267.82 8 Other comprehensive income/(loss) for the period / year Itemsthatwillnotbereclassifiedsubsequentlytoprofit or loss Remeasurement of net defined benefit liability - 1.18 - (0.21) Incometaxrelatingtoitemsthatwillnotbereclassified - (0.30) - 0.05 to profit or loss Other comprehensive income/(loss), net of taxes - 0.88 - (0.16) 9 Total comprehensive income/(loss) (7+8) (14.30) 28.34 80.59 267.66 10 Paid-up equity share capital (Face value of INR 10 518.13 518.13 518.13 518.13 each) 11 Other equity 3,848.09 12 Earnings/(Loss) per share (Face value of INR 10 each) Not annualised Not annualised Not annualised Annualised Basic (in INR) (0.28) 0.53 1.58 5.20 Diluted (in INR) (0.28) 0.53 1.57 5.19 See accompanying notes to the Statement of Unaudited Standalone Financial Results Aster DM Quality Care Limited (Formerly known as Aster DM Healthcare Limited) CIN : L85110TS2008PLC207383 Registered office : No 7-1-450/20, Plot No-04, Mythri Vihar, Sanjeev Reddy Nagar, Ameerpet, Hyderabad, Telangana, India, 500038 Notes to the Statement of Unaudited Standalone Financial Results: 1) TheStatemento [Showing first 8,000 characters — download PDF for full document]